NCT03212053View on ClinicalTrials.gov

Prospective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET)

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 11, 2017

Primary Completion Date

August 8, 2019

Study Completion Date

August 8, 2019

Conditions
Thrombocythemia Essential
Interventions
BIOLOGICAL

biological tests of haemostasis at each consultation (Multiplate, ROTEM, VASP)

Patients will have blood samples at each consultation (2 or 3 sampling tubes) in order to carry out systematically three biological tests

Trial Locations (1)

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03212053 - Prospective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET) | Biotech Hunter | Biotech Hunter